-+ 0.00%
-+ 0.00%
-+ 0.00%

BridgeBio Oncology Therapeutics Launches Phase 1 Trial of BBO-10203 in Advanced Solid Tumors

Reuters·12/10/2025 21:05:16

Please log in to view news